FDA Inspection 1161116 — BioLife Plasma Services LP
The FDA completed an inspection of BioLife Plasma Services LP on Jan 4, 2022 in Corona, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 4, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Corona, CA (United States)